All articles tagged with #fit test
Ontario becomes the second Canadian province to lower the routine colorectal cancer screening age from 50 to 45, making at-home FIT tests available to adults 45+ with abnormal results leading to colonoscopy; PEI was first to move the age, and advocates say earlier detection saves lives and reduces costs, urging other provinces to follow suit while noting that high-risk individuals may still require colonoscopy earlier.
NHS England will lower the home bowel cancer screening threshold for the FIT test from 120 to 80 micrograms of blood per gram of feces, making screening more sensitive and enabling earlier detection of cancers and high‑risk polyps. The change is expected to identify about 600 additional cancers and 2,000 more high‑risk polyps each year, with digital NHS App alerts and a nationwide rollout by March 2028, potentially reducing late‑stage diagnoses and saving around £32m a year.
Doctors are urging people in their 30s to consider the fecal immunochemical test (FIT) as a less invasive, cost-effective screening option for colorectal cancer, which can significantly reduce mortality if detected early. The FIT detects hidden blood in stool, indicating potential cancer or polyps, and is especially recommended for those at higher risk or under 45 who may not qualify for colonoscopies. Regular use of FIT can catch cancer early, but it should be used only if asymptomatic, with follow-up colonoscopies if results are positive.
A simple, non-invasive fecal immunochemical test (FIT) can significantly reduce the risk of dying from colorectal cancer, especially for those under 45 who are at risk or wish to start early screening. The test detects hidden blood in stool, indicating potential cancer or polyps, and is highly effective, affordable, and accessible, making it a valuable tool for early detection and prevention.
The fecal immunochemical test (FIT) is a fast, accurate, and easy-to-use test that detects elevated globin, the most predictive biomarker of colon and rectal cancer, in the gastrointestinal tract. The second-generation FIT test is a revolutionary test that aids in the detection of colorectal cancer, colitis, diverticulitis, and other lower GI disease states. FIT is a simple, cost-effective option that can be completed in the doctor’s office or taken home for sample collection and returned to the doctor, which helps to refer the right patients to get a colonoscopy. FIT has been recommended by the World Health Organization, the American College of Gastroenterology, the American Gastroenterological Association, the US Joint Preventative Task Force, and the American Cancer Society for colon cancer screening, with outcomes similar to screening with colonoscopy.